• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Get the next $MTD alert in real time by email

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights:

    • Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions.
    • Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules.

    Fourth Quarter Results

    Patrick Kaltenbach, President and Chief Executive Officer, stated, "We had a great finish to the year with broad based growth by geography and product category. Our team continues to execute very well in a challenging environment and delivered strong Adjusted EPS growth for the quarter with excellent free cash flow conversion for the year."

    GAAP Results

    EPS in the quarter was $13.98, compared with the prior-year amount of $11.96, and included a non-cash discrete tax benefit of $0.95 per share.

    Compared with the prior year, total reported sales increased 8% to $1.130 billion. By region, reported sales increased 7% in the Americas, 12% in Europe, and 5% in Asia/Rest of World. Earnings before taxes amounted to $329.1 million, compared with $314.5 million in the prior year.

    Non-GAAP Results

    Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41.

    Compared with the prior year, total sales in local currency increased 5%. By region, local currency sales increased 7% in the Americas, 4% in Europe, and 4% in Asia/Rest of World. Excluding acquisitions, fourth quarter local currency sales increased 4%, including 4% growth in the Americas. Adjusted Operating Profit amounted to $363.0 million, compared with the prior-year amount of $351.9 million.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Full Year Results

    GAAP Results

    EPS was $42.05, compared with the prior-year amount of $40.48. Results in 2025 included a non-cash discrete tax benefit of $0.95 per share, while results in 2024 included a non-cash discrete tax benefit of $1.07 per share.

    Compared with the prior year, total reported sales increased 4% to $4.026 billion. By region, reported sales increased 5% in the Americas, 6% in Europe, and 2% in Asia/Rest of World. Earnings before taxes amounted to $1.049 billion, compared with $1.037 billion in the prior year.

    Non-GAAP Results

    Adjusted EPS was $42.73, an increase of 4% over the prior-year amount of $41.11.

    Total sales in local currency increased 3% compared with the prior year. By region, local currency sales increased 5% in the Americas, 1% in Europe, and 2% in Asia/Rest of World. Excluding acquisitions and the impact from delayed fourth quarter 2023 shipments that benefited first quarter 2024 sales, full year 2025 local currency sales increased 4%, including 4% growth in the Americas, 3% growth in Europe, and 3% growth in Asia/Rest of World. Adjusted Operating Profit amounted to $1.193 billion, compared with the prior-year amount of $1.200 billion.

    Adjusted EPS and Adjusted Operating Profit are non-GAAP measures. Reconciliations to the most comparable GAAP measures are provided in the attached schedules.

    Outlook

    Management cautions that market conditions are uncertain and could change quickly. Based on today's assessment, management anticipates local currency sales for the first quarter of 2026 will increase approximately 3%. Adjusted EPS is forecast to be $8.60 to $8.75, a growth rate of 5% to 7%.

    For the full year 2026, management anticipates local currency sales will increase approximately 4%. Adjusted EPS is forecast to be in the range of $46.05 to $46.70, representing growth of approximately 8% to 9%. This compares with previous local currency sales growth guidance of approximately 4% and Adjusted EPS guidance of $45.35 to $46.00.

    The Company does not provide GAAP financial measures on a forward-looking basis because we are unable to predict with reasonable certainty and without unreasonable effort the timing and amount of future restructuring and other non-recurring items.

    Conclusion

    Kaltenbach concluded, "I am very proud of our organization's resilience and agility over the past year as we successfully navigated challenges posed by global trade disputes and soft market conditions, and we remain agile in this dynamic environment. Looking ahead, we are very well positioned to drive growth with our Spinnaker sales and marketing program and innovative product portfolio while capitalizing on opportunities related to automation, digitalization, and onshoring investments around the world. Our strategic initiatives and strong culture of innovation and operational excellence are deeply embedded in the organization and will help us continue to gain share and deliver strong financial performance."

    Other Matters

    The Company will host a conference call to discuss its quarterly results tomorrow morning (Friday, February 6) at 8:30 a.m. Eastern Time. To listen to a live webcast or replay of the call, visit the investor relations page on the Company's website at investor.mt.com. The presentation referenced on the conference call will be located on the website prior to the call.

    METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader and our solutions are critical in key R&D, quality control, and manufacturing processes for customers in a wide range of industries including life sciences, food, and chemicals. Our sales and service network is one of the most extensive in the industry. Our products are sold in more than 140 countries and we have a direct presence in approximately 40 countries. With proven growth strategies and a focus on execution, we have achieved a long-term track record of strong financial performance. For more information, please visit www.mt.com.

    Forward-Looking Statements Disclaimer

    You should not rely on forward-looking statements to predict our actual results. Our actual results or performance may be materially different than reflected in forward-looking statements because of various risks and uncertainties. You can identify forward-looking statements by terminology such as "may," "will," "could," "would," "should," "expect," "plan," "anticipate," "intend," "believe," "estimate," "predict," "potential," or "continue."

    We make forward-looking statements in this Quarterly Report about future events or our future financial performance, including sales and earnings growth, earnings per share, strategic plans and contingency plans, growth opportunities or economic downturns, our ability to respond to changes in market conditions, planned research and development efforts and product introductions, adequacy of facilities, access to and the costs of raw materials, shipping and supplier costs, gross margins, customer demand, our competitive position, pricing, capital expenditures, cash flow, share repurchases, tax-related matters, the impact of foreign currencies, compliance with laws, effects of acquisitions, the impact of inflation, ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, the conflict in Ukraine and continuing instability in the Middle East on our business.

    Our forward-looking statements may not be accurate or complete, speak only as of the date of this Quarterly Report, and we do not intend to update or revise them in light of actual results. New risks also periodically arise. Please consider the risks and factors that could cause our results to differ materially from what is described in our forward-looking statements, including ongoing developments related to global trade disputes/tariffs, governmental policies, the geopolitical environment, inflation, the conflict in Ukraine and continuing instability in the Middle East. See in particular "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other reports filed with the SEC from time to time.

    METTLER-TOLEDO INTERNATIONAL INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)

     

    Three months ended

     

     

    Three months ended

     

    December 31, 2025

     

    % of sales

    December 31, 2024

    % of sales

     

    Net sales

    $1,129,735

    (a)

    100.0

    $1,045,127

    100.0

    Cost of sales

    454,300

     

    40.2

    405,812

    38.8

    Gross profit

    675,435

     

    59.8

    639,315

    61.2

     

    Research and development

    52,599

     

    4.7

    50,054

    4.8

    Selling, general and administrative

    259,826

     

    23.0

    237,340

    22.7

    Amortization

    19,673

     

    1.8

    18,220

    1.8

    Interest expense

    17,388

     

    1.5

    17,850

    1.7

    Restructuring charges

    4,572

     

    0.4

    2,147

    0.2

    Other charges (income), net

    (7,697)

     

    (0.7)

    (843)

    (0.1)

    Earnings before taxes

    329,074

     

    29.1

    314,547

    30.1

     

    Provision for taxes

    43,309

     

    3.8

    62,246

    6.0

    Net earnings

    $285,765

     

    25.3

    $252,301

    24.1

     

    Basic earnings per common share:

     

    Net earnings

    $14.02

     

    $12.00

    Weighted average number of common shares

    20,380,453

     

    21,024,024

     

    Diluted earnings per common share:

     

    Net earnings

    $13.98

     

    $11.96

    Weighted average number of common

    20,444,484

     

    21,101,360

    and common equivalent shares

     

     

    Note:

     

    (a) Local currency sales increased 5% as compared to the same period in 2024.

     

    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT

     

    Three months ended

     

     

    Three months ended

     

    December 31, 2025

     

    % of sales

    December 31, 2024

    % of sales

     

    Earnings before taxes

    $329,074

     

    $314,547

    Amortization

    19,673

     

    18,220

    Interest expense

    17,388

     

    17,850

    Restructuring charges

    4,572

     

    2,147

    Other charges (income), net

    (7,697)

     

    (843)

    Adjusted operating profit

    $363,010

    (b)

    32.1

    $351,921

    33.7

     

    Note:

     

    (b) Adjusted operating profit increased 3% as compared to the same period in 2024.

    METTLER-TOLEDO INTERNATIONAL INC.
    CONSOLIDATED STATEMENTS OF OPERATIONS
    (amounts in thousands except share data)
    (unaudited)

     

    Twelve months ended

     

     

    Twelve months ended

     

    December 31, 2025

     

    % of sales

    December 31, 2024

    % of sales

     

    Net sales

    $4,026,399

    (a)

    100.0

    $3,872,361

    100.0

    Cost of sales

    1,635,753

     

    40.6

    1,546,778

    39.9

    Gross profit

    2,390,646

     

    59.4

    2,325,583

    60.1

     

    Research and development

    199,373

     

    5.0

    189,357

    4.9

    Selling, general and administrative

    998,314

     

    24.8

    936,303

    24.2

    Amortization

    74,469

     

    1.8

    72,869

    1.9

    Interest expense

    68,515

     

    1.7

    74,631

    1.9

    Restructuring charges

    17,868

     

    0.4

    19,771

    0.5

    Other charges (income), net

    (16,802)

     

    (0.4)

    (4,571)

    (0.1)

    Earnings before taxes

    1,048,909

     

    26.1

    1,037,223

    26.8

     

    Provision for taxes

    179,716

     

    4.5

    174,083

    4.5

    Net earnings

    $869,193

     

    21.6

    $863,140

    22.3

     

    Basic earnings per common share:

     

    Net earnings

    $42.17

     

    $40.67

    Weighted average number of common shares

    20,610,189

     

    21,221,839

     

    Diluted earnings per common share:

     

    Net earnings

    $42.05

     

    $40.48

    Weighted average number of common

    20,671,708

     

    21,320,641

    and common equivalent shares

     

     

    Note:

     

    (a) Local currency sales increased 3% as compared to the same period in 2024.

     
    RECONCILIATION OF EARNINGS BEFORE TAXES TO ADJUSTED OPERATING PROFIT

     

    Twelve months ended

     

     

     

    Twelve months ended

     

     

    December 31, 2025

     

    % of sales

     

    December 31, 2024

     

    % of sales

     

    Earnings before taxes

    $1,048,909

     

    $1,037,223

    Amortization

    74,469

     

    72,869

    Interest expense

    68,515

     

    74,631

    Restructuring charges

    17,868

     

    19,771

    Other charges (income), net

    (16,802)

     

    (4,571)

    Adjusted operating profit

    $1,192,959

    (b)

    29.6

    $1,199,923

    31.0

     

    Note:

     

    (b) Adjusted operating profit decreased 1% as compared to the same period in 2024.

    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED BALANCE SHEETS
    (amounts in thousands)
    (unaudited)
     
     
    December 31, 2025 December 31, 2024
     
    Cash and cash equivalents

    $66,888

    $59,362

    Accounts receivable, net

    778,243

    687,112

    Inventories

    387,228

    342,274

    Other current assets and prepaid expenses

    130,308

    105,158

    Total current assets

    1,362,667

    1,193,906

     
    Property, plant and equipment, net

    845,636

    770,280

    Goodwill and other intangibles assets, net

    1,018,135

    926,057

    Other non-current assets

    486,208

    349,756

    Total assets

    $3,712,646

    $3,239,999

     
    Short-term borrowings and maturities of long-term debt

    $63,931

    $182,623

    Trade accounts payable

    266,628

    215,843

    Accrued and other current liabilities

    867,557

    769,727

    Total current liabilities

    1,198,116

    1,168,193

     
    Long-term debt

    2,088,241

    1,831,265

    Other non-current liabilities

    449,925

    367,431

    Total liabilities

    3,736,282

    3,366,889

     
    Shareholders' equity

    (23,636)

    (126,890)

    Total liabilities and shareholders' equity

    $3,712,646

    $3,239,999

    METTLER-TOLEDO INTERNATIONAL INC.
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
    (amounts in thousands)
    (unaudited)
     
    Three months ended Twelve months ended
    December 31, December 31,

    2025

     

    2024

     

    2025

     

    2024

     
    Cash flow from operating activities:
    Net earnings

    $285,765

    $252,301

    $869,193

    $863,140

    Adjustments to reconcile net earnings to net cash provided by operating activities:
    Depreciation

    13,092

    12,643

    51,141

    50,352

    Amortization

    19,673

    18,220

    74,469

    72,869

    Deferred tax provision (benefit)

    22,598

    (155)

    17,471

    (5,216)

    Share-based compensation

    6,485

    6,357

    22,512

    19,979

    Non-cash discrete current tax benefit

    (13,685)

    -

    (13,685)

    (22,982)

    Increase (decrease) in cash resulting from changes in operating assets and liabilities

    (108,343)

    (23,179)

    (65,329)

    (9,796)

    Net cash provided by operating activities

    225,585

    266,187

    955,772

    968,346

     
    Cash flows from investing activities:
    Proceeds from sale of property, plant and equipment

    -

    898

    -

    1,631

    Purchase of property, plant and equipment

    (41,504)

    (41,276)

    (107,124)

    (103,898)

    Proceeds from government funding

    6,170

    -

    6,170

    -

    Acquisitions

    (18,411)

    (7,618)

    (93,839)

    (10,091)

    Other investing activities

    13,340

    (3,056)

    919

    (7,104)

    Net cash used in investing activities

    (40,405)

    (51,052)

    (193,874)

    (119,462)

     
    Cash flows from financing activities:
    Proceeds from borrowings

    438,015

    594,916

    1,996,222

    2,156,565

    Repayments of borrowings

    (499,825)

    (598,429)

    (1,974,762)

    (2,175,291)

    Proceeds from exercise of stock options

    21,414

    1,380

    32,273

    23,719

    Repurchases of common stock

    (143,749)

    (212,500)

    (799,995)

    (849,997)

    Payments of excise tax on repurchases of common stock

    (7,750)

    (8,089)

    (7,750)

    (8,089)

    Other financing activities

    (241)

    (971)

    (1,161)

    (2,884)

    Net cash used in financing activities

    (192,136)

    (223,693)

    (755,173)

    (855,977)

     
    Effect of exchange rate changes on cash and cash equivalents

    4,779

    (3,654)

    801

    (3,352)

     
    Net increase (decrease) in cash and cash equivalents

    (2,177)

    (12,212)

    7,526

    (10,445)

     
    Cash and cash equivalents:
    Beginning of period

    69,065

    71,574

    59,362

    69,807

    End of period

    $66,888

    $59,362

    $66,888

    $59,362

     
    RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW
     
    Three months ended Twelve months ended
    December 31, December 31,

    2025

     

    2024

     

    2025

     

    2024

    Net cash provided by operating activities

    $225,585

    $266,187

    $955,772

    $968,346

    Payments in respect of restructuring activities

    3,988

    3,986

    14,582

    23,752

    Payments for acquisition transaction costs

    -

    -

    901

    -

    Transition tax payment

    -

    -

    13,404

    10,723

    Proceeds from sale of property, plant and equipment

    -

    898

    -

    1,631

    Purchase of property, plant and equipment, net

    (41,504)

    (41,276)

    (107,124)

    (103,898)

    Adjusted free cash flow

    $188,069

    $229,795

    $877,535

    $900,554

     
    METTLER-TOLEDO INTERNATIONAL INC.
    OTHER OPERATING STATISTICS
     
    SALES GROWTH BY DESTINATION
    (unaudited)
     
    Americas Europe

    Asia/RoW

    Total
     
    U.S. Dollar Sales Growth
    Three Months Ended December 31, 2025

    7%

     

    12%

     

    5%

     

    8%

    Twelve Months Ended December 31, 2025

    5%

     

    6%

     

    2%

     

    4%

     

     

     

     

     

     

     

    Local Currency Sales Growth

     

     

     

     

     

     

     

    Three Months Ended December 31, 2025

    7%

     

    4%

     

    4%

     

    5%

    Twelve Months Ended December 31, 2025

    5%

     

    1%

     

    2%

     

    3%

    Note:

    (a)

    Net sales growth in local currency excluding acquisitions was 4%, including growth of 4% in the Americas, for the three months ended December 31, 2025.

    (b)

    The Company estimates net sales growth in local currency was 4% excluding acquisitions and the impact from delayed fourth quarter 2023 shipments that benefited first quarter 2024 sales, and by geographic destination increased by 4% in the Americas, 3% in Europe and 3% in Asia/Rest of World for the twelve months ended December 31, 2025.

    RECONCILIATION OF DILUTED EPS AS REPORTED TO ADJUSTED DILUTED EPS
    (unaudited)

     

     

     

     

    Three months ended Twelve months ended
    December 31, December 31,

    2025

     

    2024

     

    % Growth

    2025

     

    2024

     

    % Growth

     

     

     

     

     

     

     

     

     

     

    EPS as reported, diluted

    $13.98

     

    $11.96

     

    17%

    $42.05

     

    $40.48

     

    4%

     

     

     

     

     

     

     

     

     

     

    Purchased intangible amortization, net of tax

    0.28

    (a)

    0.24

    (a)

     

    1.02

    (a)

    0.94

    (a)

     

    Restructuring and other, net of tax

    0.18

    (b)

    0.09

    (b)

     

    0.70

    (b)

    0.76

    (b)

     

    Acquisition costs, net of tax

    (0.14)

    (c)

     

     

     

    (0.09)

    (c)

     

     

     

    Income tax expense

    (0.94)

    (d)

    0.12

    (d)

     

    (0.95)

    (d)

    (1.07)

    (d)

     

     

     

     

     

     

     

     

     

     

     

    Adjusted EPS, diluted

    $13.36

     

    $12.41

     

    8%

    $42.73

     

    $41.11

     

    4%

    Notes:

    (a)

    Represents the EPS impact of purchased intangibles amortization of $7.5 million ($5.7 million net of tax) and $6.4 million ($5.0 million net of tax) for the three months ended December 31, 2025 and 2024, respectively, and of $27.3 million ($21.1 million net of tax) and $25.9 million ($20.1 million net of tax) for the twelve months ended December 31, 2025 and 2024, respectively.

    (b)

    Represents the EPS impact of restructuring charges of $4.6 million ($3.7 million after tax) and $2.1 million ($1.7 million after tax) for the three months ended December 31, 2025 and 2024, respectively, and of $17.9 million ($14.5 million after tax) and $19.8 million ($16.0 million after tax) for the twelve months ended December 31, 2025 and 2024, respectively, which primarily include employee related costs; and other costs of $0.3 million ($0.3 million after tax) for the three and twelve months ended December 31, 2024.

    (c)

    Represents the EPS impact of a net benefit of $4.4 million ($3.6 million net of tax) related to contingent consideration associated with previous acquisitions less acquisition transaction costs of $0.9 million ($0.7 million net of tax) and $2.2 million ($1.7 million net of tax) for the three and twelve months ended December 31, 2025, respectively.

    (d)

    Represents the EPS impact of the difference between our quarterly and estimated annual tax rate before non-recurring discrete items during the three months ended December 31, 2025 and 2024 due to the timing of excess tax benefits associated with stock option exercises. Also includes a reported EPS reduction of $0.95 for the three and twelve months ended December 31, 2025 and $1.07 for the twelve months ended December 31, 2024, respectively, for non-cash discrete tax benefits resulting from the reduction of uncertain tax position liabilities and valuation allowance related to the settlement of tax audits.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260205775735/en/

    Adam Uhlman

    Head of Investor Relations

    METTLER TOLEDO

    Direct: 614-438-4794

    adam.uhlman@mt.com

    Get the next $MTD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MTD

    DatePrice TargetRatingAnalyst
    12/15/2025$1600.00Neutral → Buy
    BofA Securities
    12/9/2025$1475.00Neutral
    Goldman
    12/2/2025$1550.00Equal-Weight
    Morgan Stanley
    6/24/2025$1325.00Overweight
    Barclays
    5/20/2025$1350.00Neutral → Buy
    UBS
    5/5/2025$1110.00Underperform → Hold
    Jefferies
    5/5/2025$1100.00Underperform → Hold
    Jefferies
    4/7/2025$1400.00Neutral → Buy
    Citigroup
    More analyst ratings

    $MTD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Mettler-Toledo upgraded by BofA Securities with a new price target

    BofA Securities upgraded Mettler-Toledo from Neutral to Buy and set a new price target of $1,600.00

    12/15/25 9:08:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Goldman initiated coverage on Mettler-Toledo with a new price target

    Goldman initiated coverage of Mettler-Toledo with a rating of Neutral and set a new price target of $1,475.00

    12/9/25 8:51:34 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Morgan Stanley initiated coverage on Mettler-Toledo with a new price target

    Morgan Stanley initiated coverage of Mettler-Toledo with a rating of Equal-Weight and set a new price target of $1,550.00

    12/2/25 8:27:37 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    SEC Filings

    View All

    SEC Form 10-K filed by Mettler-Toledo International Inc.

    10-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/6/26 11:53:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    2/5/26 4:39:49 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Filer)

    1/20/26 5:02:04 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an

    1/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Tokich Michael J

    3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    2/6/26 11:23:00 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    New insider Wittorf Oliver claimed ownership of 408 shares (SEC Form 3)

    3 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    1/9/26 11:26:25 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Head of Eur & NA Market Orgs De La Guerroniere Marc sold $9,010,900 worth of shares (6,055 units at $1,488.18) and exercised 6,055 shares at a strike of $877.33 (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/26/25 10:38:50 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Diggelmann Roland D bought $323,360 worth of shares (315 units at $1,026.54), increasing direct ownership by 350% to 405 units (SEC Form 4)

    4 - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Issuer)

    11/15/23 9:00:20 AM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Leadership Updates

    Live Leadership Updates

    View All

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

    Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced a series of leadership and governance enhancements designed to support the Company's next phase of growth. These changes include the appointment of two highly accomplished life sciences executives, Garret Hampton, Ph.D., and Alan Sachs, M.D., Ph.D., to the Company's Board of Directors, effective immediately. Dr. Hampton most recently served as

    11/20/25 4:15:00 PM ET
    $EXAS
    $IDYA
    $ILMN
    Medical Specialities
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Industrial Machinery/Components

    Pablo Perversi to Join METTLER TOLEDO Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Pablo Perversi has been appointed to its Board of Directors, effective November 6, 2025. Mr. Perversi is the President of Europe at Danone, a leading global food and beverage company, and a member of its Executive Committee. Prior to his current role, Pablo served as Chief Innovation, Quality, and Sustainability Officer and President of Gourmet Division for Barry Callebaut from 2017 to 2022. Before that, he held various roles of increasing responsibility at Unilever from 1993 to 2017, his last position there being Vice President of Foods Europe. Roland Diggelmann, Chair of the Board, stated, "Pablo is a very accomplished

    8/4/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Financials

    Live finance-specific insights

    View All

    Mettler-Toledo International Inc. Reports Fourth Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced fourth quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 5% compared with the prior year and included a 1% benefit from acquisitions. Net earnings per diluted share as reported (EPS) were $13.98, compared with $11.96 in the prior-year period. Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Fourth Quarter Results Patrick Kaltenbach, President and Chief Executive Office

    2/5/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. to Host Fourth Quarter 2025 Earnings Conference Call

    Mettler-Toledo International Inc. (NYSE:MTD) announced it will release its fourth quarter 2025 financial results after the market close on Thursday, February 5, 2026. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company's website, investor.mt.com. METTLER TOLEDO (NYSE:MTD) is a leading global supplier of precision instruments and services. We have strong leadership positions in all of our businesses and believe we hold global number-one market positions in most of them. We are recognized as an innovation leader an

    1/9/26 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Mettler-Toledo International Inc. Reports Third Quarter 2025 Results

    Mettler-Toledo International Inc. (NYSE:MTD) today announced third quarter results for 2025. Provided below are the highlights: Reported sales increased 8% compared with the prior year. In local currency, sales increased 6% compared with the prior year. Net earnings per diluted share as reported (EPS) were $10.57, compared with $9.96 in the prior-year period. Adjusted EPS was $11.15, an increase of 9% over the prior-year amount of $10.21. Adjusted EPS is a non-GAAP measure, and a reconciliation to EPS is included on the last page of the attached schedules. Third Quarter Results Patrick Kaltenbach, President and Chief Executive Officer, stated, "Our third quarter results were strong a

    11/6/25 4:30:00 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $MTD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/13/24 5:09:38 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/23 1:38:29 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G/A filed by Mettler-Toledo International Inc. (Amendment)

    SC 13G/A - METTLER TOLEDO INTERNATIONAL INC/ (0001037646) (Subject)

    2/10/22 5:03:51 PM ET
    $MTD
    Biotechnology: Laboratory Analytical Instruments
    Industrials